Lobbying Filing Details

Total Spending

$1,280,000

Activities

5

Lobbyists

6

Gov't Entities

25

Filing Information
Filing UUID:
b0f18fd5-941b-4149-b71b-ef5493616049
Type:
Q4 - 4th Quarter - Report
Period:
2021 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2022 at 9:34 PM
Income:
$0
Expenses:
$1,280,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Samuel Marchio
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Financial Institutions/Investments/Securities

Federal Medical Assistance Percentages (FMAP) increase
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing
APTC Expansion and Permanency
CARES Act
Blockchain

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use, Parity and compliance issues;
Surprise medical billing;
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Medicare Sequestration, ACA subsidies, COVID vaccines and testing, Consolidated Appropriations Act
Behavioral Health
Telehealth
Short Term Limited Duration health plans
Consolidated Appropriations Act, HR 133
Medical Loss Ratio; H.R. 3969 - To amend title XXVII of the Public Health Service Act to include activities to address social determinants of health in the calculation of medical loss ratios
Federal Medical Assistance Percentages (FMAP) increase
Special Enrollment Period
CONNECT for Health Act
Hospital Claims Form Issues
H.R.5376 - Build Back Better Act
KEEP Telehealth Options Act
Opioid use disorders (OUD) and substance use disorders (SUD) treatment
Agent/broker compensation disclosures under the Consolidated Appropriations Act.
CAA regulation implementation
Hospital Competition Act
Medicaid eligibility
Health Equity/Health Disparities

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107);
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues;
Surprise medical billing;
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
COVID-19 testing, vaccines, treatment, cost sharing
Medical Loss Ratio; H.R. 3969 - To amend title XXVII of the Public Health Service Act to include activities to address social determinants of health in the calculation of medical loss ratios
Federal Medical Assistance Percentages (FMAP) increase
Short Term Limited Duration health plans
Special Enrollment Period
CONNECT for Health Act
Hospital Claims Form Issues
H.R.5376 - Build Back Better Act
KEEP Telehealth Options Act
Opioid use disorders (OUD) and substance use disorders (SUD) treatment
Agent/broker compensation disclosures under the Consolidated Appropriations Act.
CAA regulation implementation
Hospital Competition Act

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract consolidation, ESRD, audio-only telehealth
H.R. 4074 -To amend title XVIII of the Social Security Act
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicare Advantage Pilot Program in TRICARE
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Maternal health (Medicaid postpartum coverage extension, H.R.959 Black Maternal Health Momnibus Act of 2021) Helping MOMS Act of 2021
CMS Extreme & Uncontrollable Circumstances Policy
Medicare Sequester (H.R.315, S.748)
Medicare Audio-Only Telehealth (H.R.2166, S.150)
H.R. 4406, the Supporting Medicaid in the U.S. Territories Act, Continuing Resolution (CR)FY 2022
Medicaid Funding for Puerto Rico
Medicare Advantage asks regarding the underfunding and disparity for Puerto Rico
H.R.5376 - Build Back Better Act
Medicaid eligibility
Health Equity/Health Disparities

Lobbyists (6)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
  • JONATHAN BONET-RIVERA
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 5
Pharmacy

Price of prescription drugs; antitrust issues; Prescription Drug Pricing Reduction Act
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Drug Rebate Rule/Executive Order
Senate Finance Committee Prescription Drug Pricing Reduction Act
Lower Drug Costs Now Act (H.R. 3)
Drug Patent Reform
Robinson-Patman Reform

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.